Our previous studies demonstrated that striatal expression of D2R was significantly reduced in PD rats, which may lead to an increase of corticostriatal glutamatergic transmission due to a decrease in endocannabinoid system activity [21]. This evidence concerns the gene DRD2 and Parkinson disease.